Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

CVRx, Inc. Common Stock (CVRX)

Surgical & Medical Instruments & Apparatus

https://www.cvrx.com

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

9201 WEST BROADWAY AVENUE, SUITE 650
MINNEAPOLIS, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/30/2021

Market Cap

178,207,026

Shares Outstanding

20,820,000

Weighted SO

20,815,635

Total Employees

N/A

Upcoming Earnings

07/29/2024

Similar Tickers

OSA --.--%

LIVN --.--%

ELMD --.--%

ELMD --.--%

KIDS --.--%

SRDX --.--%

LUNG --.--%

HSKA --.--%

OFIX --.--%

Beta

1.2030

Last Div

0.0000

Range

6.4-33.135

Chg

0.1700

Avg Vol

373795

Mkt Cap

178207026

Exch

NASDAQ

Country

US

Phone

763 416 2840

DCF Diff

23.9282

DCF

-0.1782

Div Yield

0.0000

P/S

4.0143

EV Multiple

-2.6201

P/FV

3.2023

Div Yield %

0.0000

P/E

-3.2529

PEG

-2.1903

Payout

0.0000

Current Ratio

10.0802

Quick Ratio

8.8503

Cash Ratio

7.7142

DSO

70.7587

DIO

569.1525

Op Cycle

639.9112

DPO

178.2912

CCC

461.6200

Gross Margin

0.8379

Op Margin

-1.2478

Pretax Margin

-1.2216

Net Margin

-1.2252

Eff Tax Rate

-0.0029

ROA

-0.5667

ROE

-0.7762

ROCE

-0.6378

NI/EBT

1.0029

EBT/EBIT

0.9790

EBIT/Rev

-1.2478

Debt Ratio

0.3080

D/E

0.5352

LT Debt/Cap

0.3467

Total Debt/Cap

0.3486

Int Coverage

65.8668

CF/Debt

-1.2410

Equity Multi

1.7373

Rec Turnover

5.1584

Pay Turnover

2.0472

Inv Turnover

0.6413

FA Turnover

11.2019

Asset Turnover

0.4625

OCF/Share

-1.6964

FCF/Share

-1.7648

Cash/Share

3.2550

OCF/Sales

-0.8265

FCF/OCF

1.0403

CF Coverage

-1.2410

ST Coverage

-148.5425

CapEx Coverage

-24.7905

Div&CapEx Cov

-24.7905

P/BV

3.2023

P/B

3.2023

P/S

4.0143

P/E

-3.2529

P/FCF

-4.6688

P/OCF

-4.8221

P/CF

-4.8221

PEG

-2.1903

P/S

4.0143

EV Multiple

-2.6201

P/FV

3.2023

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Aug 27, 01:00 Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 11, 16:30 CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024 GlobeNewswire Inc. Dec 27, 16:30 CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 27, 16:30 CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference Benzinga Dec 27, 12:00 Lake Street Maintains Buy Rating for CVRx: Here's What You Need To Know GlobeNewswire Inc. Dec 26, 08:05 CVRx receives FDA approval for expanded labeling of Barostim The Motley Fool Nov 16, 05:50 Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On GlobeNewswire Inc. Nov 15, 16:21 CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

Revenue Product Segmentation